| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hansol Kang, Christopher J Schmoyer, Alexandra Weiss, James D Lewi. Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease. Inflammatory bowel diseases. 2024-08-28. PMID:39197096. |
with the increasing legalization of medical and recreational cannabis, patients and providers have growing interest in the role of cannabinoids in treating inflammatory bowel disease. |
2024-08-28 |
2024-08-31 |
Not clear |
| Nicol Kolar, Ezgi Eyluel Bankoglu, Helga Stoppe. Genotoxicity of selected cannabinoids in human lymphoblastoid TK6 cells. Archives of toxicology. 2024-08-22. PMID:39172143. |
natural non-psychoactive cannabinoids such as cannabigerol (cbg), cannabidiol (cbd), cannabichromene (cbc), cannabidivarin (cbdv), and cannabinol (cbn) are increasingly consumed as constituents of dietary products because of the health benefits claims. |
2024-08-22 |
2024-08-24 |
human |
| Mark M Mims, Aniruddha C Parikh, Zainab Sandhu, Noah DeMoss, Rachad Mhawej, Lurdes Queimad. Surgery-Related Considerations in Treating People Who Use Cannabis: A Review. JAMA otolaryngology-- head & neck surgery. 2024-08-22. PMID:39172477. |
these cannabinoid substances have various systemic effects, and it is critical for otolaryngologists to recognize how cannabis use may contribute to a patient's care. |
2024-08-22 |
2024-08-24 |
Not clear |
| William L Hasler, Omayma Alshaarawy, Thangam Venkatesa. Cannabis use patterns and association with hyperemesis: A comprehensive review. Neurogastroenterology and motility. 2024-08-21. PMID:39164887. |
cannabis has documented antiemetic properties and cannabinoid pharmaceuticals are used in disorders like chemotherapy-induced nausea and vomiting. |
2024-08-21 |
2024-08-23 |
Not clear |
| Elizabeth S Thompson, Jane Alcorn, J Patrick Near. Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport. Sports medicine (Auckland, N.Z.). 2024-08-21. PMID:39168949. |
cannabinoid therapy in athletics: a review of current cannabis research to evaluate potential real-world cannabinoid applications in sport. |
2024-08-21 |
2024-08-24 |
Not clear |
| Elizabeth S Thompson, Jane Alcorn, J Patrick Near. Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport. Sports medicine (Auckland, N.Z.). 2024-08-21. PMID:39168949. |
the changing legal landscape, especially the removal of cannabis from drug testing programs in leagues such as the national basketball association (nba), and endorsements by major league baseball (mlb) for cannabinoid products and the national football league (nfl) for cannabis research, reflects a shift in the acceptability of such substances in sports. |
2024-08-21 |
2024-08-24 |
Not clear |
| Elizabeth S Thompson, Jane Alcorn, J Patrick Near. Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport. Sports medicine (Auckland, N.Z.). 2024-08-21. PMID:39168949. |
adding to the confusion is the lack of consistency with cannabinoid regulations from sport to sport, within or out of competition, and with cannabis bioactive compounds. |
2024-08-21 |
2024-08-24 |
Not clear |
| Elizabeth S Thompson, Jane Alcorn, J Patrick Near. Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport. Sports medicine (Auckland, N.Z.). 2024-08-21. PMID:39168949. |
by synthesizing current cannabis research, this review aims to provide a comprehensive understanding of the applications and implications of cannabinoid use in the realm of athletics. |
2024-08-21 |
2024-08-24 |
Not clear |
| Alessandra Di Salvo, Elisabetta Chiaradia, Monica Sforna, Giorgia Della Rocc. Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review. Veterinary research communications. 2024-08-20. PMID:39162768. |
this manuscript summarizes the findings reported by the scientific studies published so far on the molecular mode of action of the main phytocannabinoids, the localization of cannabinoid receptors in organs and tissues, as well as the pharmacokinetics, efficacy and tolerability of cannabis derivatives in dogs, cats, horses and other species of veterinary interest. |
2024-08-20 |
2024-08-22 |
Not clear |
| Magen N Lord, Emily E Nobl. Hypothalamic cannabinoid signaling: Consequences for eating behavior. Pharmacology research & perspectives. vol 12. issue 5. 2024-08-19. PMID:39155548. |
in parallel to the legalization of cannabis for both medicinal and recreational purposes, cannabinoid use has steadily increased over the last decade in the united states. |
2024-08-19 |
2024-08-21 |
Not clear |
| Omar Oraib. From Chronic Cannabis to Cyclic Chaos: A Glimpse Into Cannabinoid Hyperemesis Syndrome. Cureus. vol 16. issue 7. 2024-08-19. PMID:39156386. |
from chronic cannabis to cyclic chaos: a glimpse into cannabinoid hyperemesis syndrome. |
2024-08-19 |
2024-08-21 |
Not clear |
| Omar Oraib. From Chronic Cannabis to Cyclic Chaos: A Glimpse Into Cannabinoid Hyperemesis Syndrome. Cureus. vol 16. issue 7. 2024-08-19. PMID:39156386. |
this case illustrates the diagnostic difficulties of cannabinoid hyperemesis syndrome (chs) in cannabis users with significant gastrointestinal symptoms. |
2024-08-19 |
2024-08-21 |
Not clear |
| Garrison J B Dyck, Zaid H Maayah, Dean T Eurich, Jason R B Dyc. Understanding the Potential Benefits of Cannabidiol for Patients With Schizophrenia: A Narrative Review. Schizophrenia bulletin open. vol 3. issue 1. 2024-08-15. PMID:39144756. |
however, studies have shown that another major cannabinoid found in cannabis, cannabidiol (cbd), may be a potential alternative or adjunctive treatment for psychosis and schizophrenia. |
2024-08-15 |
2024-08-17 |
Not clear |
| Laith Al-Eitan, Hana Abu Kharma. Effect of EMB-FUBINACA on brain endothelial cell angiogenesis: Expression analysis of angiogenic markers. Naunyn-Schmiedeberg's archives of pharmacology. 2024-08-13. PMID:39136736. |
synthetic cannabinoids represent new psychoactive substances that bind to the cannabinoid receptor 1 (cb1r) and cannabinoid receptor 2 (cb2r) and simulate similar effects of tetrahydrocannabinol, the primary component found in cannabis. |
2024-08-13 |
2024-08-16 |
human |
| Carolina Henkes Inamassu, Luisa Raspini E Silva, Camila Marchion. Recent advances in the chromatographic analysis of endocannabinoids and phytocannabinoids in biological samples. Journal of chromatography. A. vol 1732. 2024-08-11. PMID:39128236. |
endocannabinoid system, including endocannabinoid neurotransmitters (ecbs), has gained much attention over the last years due to its involvement with the pathophysiology of diseases and the potential use of cannabis sativa (marijuana). |
2024-08-11 |
2024-08-14 |
Not clear |
| Martina Di Bartolomeo, Andrea Čerňanová, Veronika Petrušová, Serena Di Martino, Július Hodosy, Filippo Drago, Vincenzo Micale, Claudio D'Addari. DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: is there an effect of Cannabis use? Pharmacological research. 2024-08-10. PMID:39127265. |
dna methylation at cannabinoid type 1 and dopamine d2 receptor genes in saliva samples of psychotic subjects: is there an effect of cannabis use? |
2024-08-10 |
2024-08-13 |
human |
| Stéphane Trevisiol, Marie-Agnès Popot, Patrice Garcia, Sophie Boyer, Mylène Caroff, Laura Drif, Wafek Taleb, Sophie Tendon, Yves Moulard, Ludovic Bailly-Chouriberr. In vivo comparative study of hemp straw exposure and cannabidiol oil administration in horse urine. Drug testing and analysis. 2024-08-09. PMID:39118356. |
the non-psychoactive cannabinoids cannabidiol (cbd) and cannabidiolic acid (cbda) are available on the market in different forms, mostly for their anti-inflammatory and potential analgesic properties. |
2024-08-09 |
2024-08-12 |
Not clear |
| Leslie K Kelley, Savannah H M Lightfoot, Matthew N Hill, Jason W Middleton, Nicholas W Gilpi. THC vapor inhalation attenuates hyperalgesia in rats using a chronic inflammatory pain model. The journal of pain. 2024-08-09. PMID:39121915. |
as cannabis and cannabinoids are legalized in the u.s. for medicinal and recreational use, it has become critical to determine the potential utilities and harms of cannabinoid drugs in individuals living with chronic pain. |
2024-08-09 |
2024-08-13 |
rat |
| Leslie K Kelley, Savannah H M Lightfoot, Matthew N Hill, Jason W Middleton, Nicholas W Gilpi. THC vapor inhalation attenuates hyperalgesia in rats using a chronic inflammatory pain model. The journal of pain. 2024-08-09. PMID:39121915. |
perspective: cannabinoids are thought to have potential utility in the treatment of chronic pain, but few animal studies have tested the effects of chronic thc or cannabis in animal models of chronic pain. |
2024-08-09 |
2024-08-13 |
rat |
| Amel Zertal, Kanza Alami Marrouni, Nathalie Arbour, Didier Jutras-Aswad, Marie-Pascale Pomey, Isabelle Rouleau, Alexandre Prat, Catherine Larochelle, Pierre Beaulieu, Laury Chamelian, Marie-Pierre Sylvestre, Danielle Morin, Jean-Sylvain Ouellette, Nathalie Fréjeau, Pierre Duquett. Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial. Frontiers in neurology. vol 15. 2024-08-08. PMID:39114536. |
for many years, persons with ms (pwms) have used cannabis to relax, to reduce pain and spasticity, or to improve sleep and daily functioning, despite the lack of scientific evidence on the efficacy of specific cannabinoids [i.e., tetrahydrocannabinol (thc) and cannabidiol (cbd)] on these ms symptoms. |
2024-08-08 |
2024-08-10 |
Not clear |